BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 27034112)

  • 21. O-Linked β-N-Acetylglucosamine Modification of A20 Enhances the Inhibition of NF-κB (Nuclear Factor-κB) Activation and Elicits Vascular Protection After Acute Endoluminal Arterial Injury.
    Yao D; Xu L; Xu O; Li R; Chen M; Shen H; Zhu H; Zhang F; Yao D; Chen YF; Oparil S; Zhang Z; Gong K
    Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1309-1320. PubMed ID: 29622561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
    Ashino T; Yamamoto M; Yoshida T; Numazawa S
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Periadventitial atRA citrate-based polyester membranes reduce neointimal hyperplasia and restenosis after carotid injury in rats.
    Gregory EK; Webb AR; Vercammen JM; Flynn ME; Ameer GA; Kibbe MR
    Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1419-29. PubMed ID: 25239800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transmembrane protein 66 attenuates neointimal hyperplasia after carotid artery injury by SOCE inactivation.
    Yang J; Li S; Wang Q; Yang D
    Mol Med Rep; 2019 Aug; 20(2):1436-1442. PubMed ID: 31173198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-octanoyl Dopamine Attenuates the Development of Transplant Vasculopathy in Rat Aortic Allografts Via Smooth Muscle Cell Protective Mechanisms.
    Wedel J; Hottenrott MC; Bulthuis M; Huitema S; Yard BA; Hillebrands JL
    Transplantation; 2016 Jan; 100(1):80-90. PubMed ID: 26674731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
    Torella D; Curcio A; Gasparri C; Galuppo V; De Serio D; Surace FC; Cavaliere AL; Leone A; Coppola C; Ellison GM; Indolfi C
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2935-43. PubMed ID: 17293493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human urine kininogenase attenuates balloon-induced intimal hyperplasia in rabbit carotid artery through transforming growth factor β1/Smad2/3 signaling pathway.
    Lan W; Yang F; Li Z; Liu L; Sang H; Jiang Y; Xiong Y; Zhang R
    J Vasc Surg; 2016 Oct; 64(4):1074-83. PubMed ID: 26054589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Efficacy of Systemic Doxycycline Administration as an Inhibitor of Intimal Hyperplasia after Balloon Angioplasty Arterial Injury.
    Mountain DJH; Kirkpatrick SS; Arnold JD; Buckley MR; McNally MM; Stevens SL; Freeman MB; Grandas OH
    Ann Vasc Surg; 2019 May; 57():201-209. PubMed ID: 30684618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phloretin Inhibits Platelet-derived Growth Factor-BB-induced Rat Aortic Smooth Muscle Cell Proliferation, Migration, and Neointimal Formation After Carotid Injury.
    Wang D; Wang Q; Yan G; Qiao Y; Tang C
    J Cardiovasc Pharmacol; 2015 May; 65(5):444-55. PubMed ID: 25945863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide prevents aortic neointimal hyperplasia by controlling macrophage polarization.
    Lavin B; Gómez M; Pello OM; Castejon B; Piedras MJ; Saura M; Zaragoza C
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1739-46. PubMed ID: 24925976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resolvin E1 attenuates injury-induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration.
    Liu G; Gong Y; Zhang R; Piao L; Li X; Liu Q; Yan S; Shen Y; Guo S; Zhu M; Yin H; Funk CD; Zhang J; Yu Y
    FASEB J; 2018 Oct; 32(10):5413-5425. PubMed ID: 29723062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-24 Attenuates Neointimal Hyperplasia in the Diabetic Rat Carotid Artery Injury Model by Inhibiting Wnt4 Signaling Pathway.
    Yang J; Fan Z; Yang J; Ding J; Yang C; Chen L
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uncoupling Protein 2 Inhibits Myointimal Hyperplasia in Preclinical Animal Models of Vascular Injury.
    Zhang Y; Zhang Y; Li W; Wang P; Gu R; Feng Y; Wei S; Peng K; Zhang Y; Su L; Wang Q; Li D; Yang D; Wong WT; Yang Y; Ma S
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel antioxidant 3,7-dihydroxy-isoflav-3-ene (DHIF) inhibits neointimal hyperplasia after vessel injury attenuating reactive oxygen species and nuclear factor-kappaB signaling.
    Kanellakis P; Pomilio G; Walker C; Husband A; Huang JL; Nestel P; Agrotis A; Bobik A
    Atherosclerosis; 2009 May; 204(1):66-72. PubMed ID: 18930230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xenobiotic pregnane X receptor promotes neointimal formation in balloon-injured rat carotid arteries.
    Zhang M; Zhang Z; Xie X; Yao Q; Liu J; Lai B; Xiao L; Wang N
    J Cell Physiol; 2019 Apr; 234(4):4342-4351. PubMed ID: 30132884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An essential role for stromal interaction molecule 1 in neointima formation following arterial injury.
    Guo RW; Wang H; Gao P; Li MQ; Zeng CY; Yu Y; Chen JF; Song MB; Shi YK; Huang L
    Cardiovasc Res; 2009 Mar; 81(4):660-8. PubMed ID: 19052075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of vascular smooth muscle cell proliferation and migration in vitro and neointimal hyperplasia in vivo by adenoviral-mediated atrial natriuretic peptide delivery.
    Larifla L; Déprez I; Pham I; Rideau D; Louzier V; Adam M; Eloit M; Foucan L; Adnot S; Teiger E
    J Gene Med; 2012 Jul; 14(7):459-67. PubMed ID: 22645072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of In-Stent Restenosis by Cholesteryl Ester Transfer Protein Inhibition.
    Wu BJ; Li Y; Ong KL; Sun Y; Shrestha S; Hou L; Johns D; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2333-2341. PubMed ID: 29025709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.